Abstract
Tumor angiogenesis, which is an important step in the development of cancer, is directly regulated by vascular endothelial growth factor receptor 2 (VEGFR-2). In this study, we examined the association of five potentially functional VEGFR-2 polymorphisms with glioma risk in a Chinese Han population. Three SNPs, rs2071559, rs7667298 and rs2305948, showed a statistically significant increased association with the risk of glioma (P = 0.006, 0.005, and 0.012, respectively). Both haplotype and diplotype analyses consistently revealed that subjects carrying two copies of the haplotype “CGT” had a 42% reduced glioma risk compared with their respective noncarriers. Our findings suggested that VEGFR-2 gene variants might contribute to glioma susceptibility.
Similar content being viewed by others
References
Albuquerque RJ, Hayashi T, Cho WG, Kleinman ME, Dridi S, Takeda A et al (2009) Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat Med 15:1023–1030
Becker J, Pavlakovic H, Ludewig F, Wilting F, Weich HA, Albuquerque R et al (2010) Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. Clin Cancer Res 16:1431–1441
Bondy ML, Wang LE, El-Zein R, de Andrade M, Selvan MS, Bruner JM et al (2001) Gamma-radiation sensitivity and risk of glioma. J Natl Cancer Inst 93:1553–1557
Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il’yasova D et al (2008) Brain tumor epidemiology consortium. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 113:1953–1968
Clauss M (2000) Molecular biology of the VEGF and the VEGF receptor family. Semin Thromb Hemost 26:561–569
DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114–123
Derynck R, Akhurst RJ, Balmain A (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29:117–129
Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D et al (2004) A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res 2:315–326
Ebos JM, Lee CR, Bogdanovic E, Alami J, Van Slyke P, Francia G et al (2008) Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth. Cancer Res 68:521–529
Försti A, Jin Q, Altieri A, Johansson R, Wagner K, Enquist K et al (2007) Polymorphisms in the KDR and POSTN genes: association with breast cancer susceptibility and prognosis. Breast Cancer Res Treat 101:83–93
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al (2002) The structure of haplotype blocks in the human genome. Science 296:2225–2229
Giatromanolaki A, Koukourakis MI, Sivridis E, Chlouverakis G, Vourvouhaki E, Turley H et al (2007) Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer. Eur J Clin Invest 37:878–886
Guo S, Colbert LS, Fuller M, Zhang Y, Gonzalez-Perez RR (2010) Vascular endothelial growth factor receptor-2 in breast cancer. Biochim Biophys Acta 1806:108–121
Huang H, Held-Feindt J, Buhl R, Mehdorn HM, Mentlein R (2005) Expression of VEGF and its receptors in different brain tumors. Neurol Res 4:371–377
Jin Q, Hemminki K, Enquist K, Lenner P, Grzybowska E, Klaes R et al (2005) Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 11:3647–3653
Jurinke C, van den Boom D, Cantor CR, Koster H (2002) Automated genotyping using the DNA MassArray technology. Methods Mol Biol 187:179–192
Kariyazono H, Ohno T, Khajoee V, Ihara K, Kusuhara K, Kinukawa N et al (2004) Association of vascular endothelial growth factor (VEGF) and VEGF receptor gene polymorphisms with coronary artery lesions of Kawasaki disease. Pediatr Res 56:953–959
Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY et al (2008) Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer. Clin Cancer Res 14:62–66
Leppänen VM, Prota AE, Jeltsch M, Anisimov A, Kalkkinen N, Strandin T et al (2010) Structural determinants of growth factor binding and specificity by VEGF receptor 2. Proc Natl Acad Sci U S A 107:2425–2430
Lewontin RC (1988) On measures of gametic disequilibrium. Genetics 120:849–852
Li R, Zhao Y, Fan W, Chen H, Chen Y, Liu Y et al (2011) Possible association between polymorphisms of human vascular endothelial growth factor a gene and susceptibility to glioma in a Chinese population. Int J Cancer 128:166–1675
Little MP, de Vathaire F, Shamsaldin A, Oberlin O, Campbell S, Grimaud E et al (1998) Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer 78:269–275
Liu Y, Zhang H, Zhou K, Chen L, Xu Z, Zhong Y et al (2007) Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma. Carcinogenesis 28:1906–1913
Liu Y, Zhou K, Zhang H, Shugart YY, Chen L, Xu Z et al (2008) Polymorphisms of LIG4 and XRCC4 involved in the NHEJ pathway interact to modify risk of glioma. Hum Mutat 29:381–389
Ohgaki H, Kleihues P (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109:93–108
Park HW, Lee JE, Shin ES, Lee JY, Bahn JW, Oh HB et al (2006) Association between genetic variations of vascular endothelial growth factor receptor 2 and atopy in the Korean population. J Allergy Clin Immunol 117:774–779
Puputti M, Tynninen O, Sihto H, Blom T, Mäenpää H, Isola J et al (2006) Amplification of KIT, PDGFRA, VEGFR2, and EGFR in gliomas. Mol Cancer Res 4:927–934
Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M (1996) Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor. Cell Growth Differ 7:213–221
Seetharam L, Gotoh N, Maru Y, Neufeld G, Yamaguchi S, Shibuya M (1995) A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF. Oncogene 10:135–147
Silva SR, Bowen KA, Rychahou PG, Jackson LN, Weiss HL, Lee EY et al (2011) VEGFR-2 expression in carcinoid cancer cells and its role in tumor growth and metastasis. Int J Cancer 128:1045–1056
Sjöström S, Wibom C, Andersson U, Brännström T, Broholm H, Johansen C et al (2011) Genetic variations in VEGF and VEGFR2 and glioblastoma outcome. J Neurooncol 104:523–527
Spannuth WA, Nick AM, Jennings NB, Armaiz-Pena GN, Mangala LS, Danes CG et al (2009) Functional significance of VEGFR-2 on ovarian cancer cells. Int J Cancer 124:1045–1053
Stephens M, Donnelly P (2003) A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73:1162–1169
Tanno S, Ohsaki Y, Nakanishi K, Toyoshima E, Kikuchi K (2004) Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3. Lung Cancer 46:11–19
Wang Y, Zheng Y, Zhang W, Yu H, Lou K, Zhang Y et al (2007) Polymorphisms of KDR gene are associated with coronary heart disease. J Am Coll Cardiol 50:760–767
Zhang W, Sun K, Zhen Y, Wang D, Wang Y, Chen J et al (2009) VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence. Stroke 40:2720–2726
Acknowledgments
The authors thank Haishi Zhang and Fengping Huang for subject enrollment. They also thank all staff members of the Department of Neurosurgery of Huashan Hospital for their cooperation during data collection. This work was partially supported by the Natural Science Foundation of China (81001114), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and the Doctoral Fund of Ministry of Education of China.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Hongyan Chen and Weimen Wang contributed equally to this work.
Yao Zhao and Ying Mao jointly directed the work.
Rights and permissions
About this article
Cite this article
Chen, H., Wang, W., Xingjie, Z. et al. Association Between Genetic Variations of Vascular Endothelial Growth Factor Receptor 2 and Glioma in the Chinese Han Population. J Mol Neurosci 47, 448–457 (2012). https://doi.org/10.1007/s12031-012-9705-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-012-9705-9